XML 43 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Mar. 31, 2016
Operating activities      
Net loss $ (8,350) $ (11,721) $ (3,765)
Adjustments to reconcile loss from continuing operations to net cash provided by operating activities:      
Net restructuring, severance and other charges 227 (224) (333)
Net legal settlements 0 100 (185)
Impairments and other fair value adjustments 0 0 87
Loss on disposal of property & equipment 0 70 381
Depreciation 2,631 2,409 2,199
Amortization 1,879 1,392 1,243
Amortization of developed technology 10,016 8,012 1,022
Share-based compensation 4,688 2,427 3,405
Contingent consideration adjustment 0 0 93
Deferred income taxes (3,085) 142 23
Change in cash surrender value of company owned life insurance policies (17) (18) (564)
Changes in operating assets and liabilities:      
Accounts receivable (719) 6,372 3,237
Inventories 229 476 (2,051)
Prepaid expense 1,485 1,946 (4,532)
Accounts payable 130 554 (7,896)
Deferred revenue (2,448) (4,034) 9,364
Accrued liabilities 653 (4,250) 5,330
Income taxes receivable (19) 45 16
Other changes, net (426) (65) (226)
Net cash provided by operating activities 6,874 3,433 7,218
Investing activities      
Capital expenditures (6,140) (4,158) (5,900)
Capitalized software development costs (8,918) (11,888) (15,048)
Additional (investments in) proceeds from corporate-owned life insurance policies (27) 2,181 (65)
Net cash used in investing activities (15,085) (13,865) (21,013)
Financing activities      
Principal payments under long-term obligations (124) (117) (142)
Repurchase of common shares to satisfy employee tax withholding (1,171) (533) (435)
Net cash used in financing activities from continuing operations (1,295) (847) (577)
Payments to settle contingent consideration arising from business acquisitions 0 197 0
Effect of exchange rate changes on cash 194 (74) (87)
Net decrease in cash and cash equivalents (9,312) (11,353) (14,459)
Cash and cash equivalents at beginning of period 49,255 60,608  
Cash and cash equivalents at end of period $ 39,943 $ 49,255 $ 60,608